0001600946-23-000001.txt : 20230626
0001600946-23-000001.hdr.sgml : 20230626
20230626124649
ACCESSION NUMBER: 0001600946-23-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plassche Douglas
CENTRAL INDEX KEY: 0001600946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 231041054
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVE.
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223542636
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
FORMER COMPANY:
FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
DATE OF NAME CHANGE: 19980121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-01-03
0
0001053369
ELITE PHARMACEUTICALS INC /NV/
ELTP
0001600946
Plassche Douglas
165 LUDLOW AVE.
NORTHVALE
NJ
07647
0
1
0
0
Executive VP Operations
0
Options
0.03
2023-01-03
4
A
0
7500000
0.03
A
2024-01-03
2033-01-03
Common Stock
7500000
7500000
D
Options were awarded by the Board of Directions as part of Mr. Plassche's employment retention agreement.
The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on January 3, 2024.
Doug Plassche
2023-06-26